+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

Description Jump to:
Summary

Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Progenics Pharmaceuticals, Inc. (Progenics or 'the company') is a biopharmaceutical company focused on the development of innovative medicines and other technologies for targeting and treating cancer. Its product portfolio includes therapeutic agents such as AZERDA and PSMA TTC that are designed to precisely target cancer and prostate-specific membrane antigen ("PSMA") targeted imaging agents including PyL used to treat prostate cancer. In addition, it also enters into licensing agreements with the University of Zurich and the Paul Scherrer, The University of Western Ontario, Johns Hopkins University and with Bayers subsidiary for acquiring worldwide sublicensable rights to enhance their product candidates. The company is headquartered in New York, the US.

Scope

  • Detailed information on Progenics Pharmaceuticals, Inc. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Progenics Pharmaceuticals, Inc. in the form of a SWOT analysis
  • An in-depth view of the business model of Progenics Pharmaceuticals, Inc. including a breakdown and examination of key business segments
  • Intelligence on Progenics Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Progenics Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

  • Gain understanding of Progenics Pharmaceuticals, Inc. and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Progenics Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Progenics Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Table of Contents

Company Snapshot
  • Progenics Pharmaceuticals, Inc.: Company Overview
  • Progenics Pharmaceuticals, Inc.: Overview and Key Facts
  • Progenics Pharmaceuticals, Inc.: Overview
  • Progenics Pharmaceuticals, Inc.: Key Facts
  • Progenics Pharmaceuticals, Inc.: Key Employees
  • Progenics Pharmaceuticals, Inc.: Key Employee Biographies
  • Progenics Pharmaceuticals, Inc.: Major Products and Services
  • Progenics Pharmaceuticals, Inc.: Company History
  • Progenics Pharmaceuticals, Inc.: Management Statement
  • Progenics Pharmaceuticals, Inc.: Locations and Subsidiaries
  • Progenics Pharmaceuticals, Inc.: Key Competitors
  • Progenics Pharmaceuticals, Inc.: Company Analysis
  • Progenics Pharmaceuticals, Inc.: Business Description
  • Progenics Pharmaceuticals, Inc.: SWOT Analysis
  • Progenics Pharmaceuticals, Inc.: SWOT Overview
  • Progenics Pharmaceuticals, Inc.: Strengths
  • Progenics Pharmaceuticals, Inc.: Weaknesses
  • Progenics Pharmaceuticals, Inc.: Opportunities
  • Progenics Pharmaceuticals, Inc.: Threats
  • Progenics Pharmaceuticals, Inc.: Corporate Financial Deals Activity
  • Progenics Pharmaceuticals, Inc.: Financial Deals Overview
  • Progenics Pharmaceuticals, Inc.: Targets and Partners
  • Progenics Pharmaceuticals, Inc.: Top Deals 2017 - 2021YTD*
  • Progenics Pharmaceuticals, Inc.: Advisors
  • Progenics Pharmaceuticals, Inc.: Top Legal Advisors
  • Progenics Pharmaceuticals, Inc.: Top Financial Advisors
  • Progenics Pharmaceuticals, Inc.: Mergers and Acquisitions
  • Progenics Pharmaceuticals, Inc.: Capital Raising
  • Progenics Pharmaceuticals, Inc.: Partnership
  • Progenics Pharmaceuticals, Inc.: Private Equity and Ownership
  • Progenics Pharmaceuticals, Inc.: Recent Developments
  • Progenics Pharmaceuticals, Inc.: News and Events Summary
  • Progenics Pharmaceuticals, Inc.: Corporate Governance
  • Progenics Pharmaceuticals, Inc.: Financial Performance
  • Progenics Pharmaceuticals, Inc.: Market Developments
  • Progenics Pharmaceuticals, Inc.: Regulatory and Legal Events
  • Progenics Pharmaceuticals, Inc.: Research & Development
  • Progenics Pharmaceuticals, Inc.: Strategy and Operations

Appendix
  • Contact the Publisher
  • Methodology
  • About the Publisher

List of Tables
Table 1: Progenics Pharmaceuticals, Inc.: Key Facts
Table 2: Progenics Pharmaceuticals, Inc.: Key Employees
Table 3: Progenics Pharmaceuticals, Inc.: Company History
Table 4: Progenics Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 5: Progenics Pharmaceuticals, Inc.: Key Competitors
Table 6: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2017 - YTD*2021)
Table 8: Progenics Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Progenics Pharmaceuticals, Inc.: Targets and Partners
Table 10: Progenics Pharmaceuticals, Inc.: Top Deals 2017 - 2021YTD*
Table 11: Progenics Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Progenics Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Progenics Pharmaceuticals, Inc.: M&A Volume and Value Trend (2017 - YTD*2021)
Table 14: Progenics Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2017 - YTD*2021)
Table 15: Progenics Pharmaceuticals, Inc.: Capital Raising by Deal Type (2017 - YTD*2021)
Table 16: Progenics Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2017 - YTD*2021)
Table 17: Progenics Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2017 - YTD*2021)
Table 18: Progenics Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2017 - YTD*2021)
Table 19: Progenics Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2017 - YTD*2021)
Table 20: Progenics Pharmaceuticals, Inc.: News and Events Summary
Table 21: Progenics Pharmaceuticals, Inc.: Corporate Governance
Table 22: Progenics Pharmaceuticals, Inc.: Financial Performance
Table 23: Progenics Pharmaceuticals, Inc.: Market Developments
Table 24: Progenics Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 25: Progenics Pharmaceuticals, Inc.: Research & Development
Table 26: Progenics Pharmaceuticals, Inc.: Strategy and Operations
List of Figures
Figure 1: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2017 - YTD*2021)
Figure 3: Progenics Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Progenics Pharmaceuticals, Inc.: M&A Volume and Value Trend (2017 - YTD*2021)
Figure 5: Progenics Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2017 - YTD*2021)
Figure 6: Progenics Pharmaceuticals, Inc.: Capital Raising by Deal Type (2017 - YTD*2021)
Figure 7: Progenics Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2017 - YTD*2021)
Figure 8: Progenics Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2017 - YTD*2021)
Figure 9: Progenics Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2017 - YTD*2021)
Figure 10: Progenics Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2017 - YTD*2021)

Related Topics

Copyright © 2002-2024 Research and Markets. All Rights Reserved.